期刊
ULTRASONIC IMAGING
卷 30, 期 3, 页码 189-200出版社
SAGE PUBLICATIONS INC
DOI: 10.1177/016173460803000304
关键词
Alzheimer disease; blood-brain barrier; drug delivery system; magnetic resonance imaging; ultrasonic therapy
资金
- NIH [R21 EY018505]
- NSF CAREER [0644713.]
The spatio-temporal nature of focused ultrasound-induced blood-brain barrier (BBB) opening as a brain drug delivery method was investigated in Alzheimer's disease model mice. The left hippocampus of transgenic (APP/PS1, n = 3) and nontrarisgenic (n = 3) mice was sonicated (frequency: 1.525 MHz, peak-negative pressure: 600 kPa, pulse length: 20 ms, duty cycle: 20%, duration: 1 min) in vivo, through their intact skin and skull, after intravenous injection of microbubbles (SonoVue (R) 25 mu l). Sequential, high-field MR images (9.4 Tesla) were acquired before and after injection of gadolinium (Omniscan (TM) 0.75 ml, molecular weight: 573.7 Da) on two separate days for cach mouse. Gadolinium deposits through the ultrasound-induced BBB opening in the left hippocampus revealed significant contrast-enhancement in the MRI. On the following day, MRI revealed significant BBB closure within the same region. However, the BBB opening extent and BBB closing timeline varied in different regions within the same sonicated location. This indicates that opening and closing were dependent on the brain region targeted. No significant difference in BBB opening or closing behaviors was observed between the APP/PS1 and the nontransgenic mice. In conclusion, a BBB-impermeable molecule was noninvasively, transiently and reproducibly delivered to the hippocampus of Alzheimer's APP/PS1 mice.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据